Press Releases - 2021-07-22

Date	Title	Company
22-Jul-2021	Optimal orientation aid for patients	Faller Packaging
22-Jul-2021	Biotech firm that ‘could revolutionise woundcare’ raises £1.8m	NuVision Biotherapies
22-Jul-2021	Growth in the Robotic Surgery Market Advancing the Endoscopy Equipment Market	Markets and Markets
22-Jul-2021	Telehealth as a Means of Providing Care Services Advancing the Behavioral Software Market	MarketsandMarkets
22-Jul-2021	Technological Advancements and Focus on Telehealth Advancing the Home Healthcare Market	Markets and Markets
22-Jul-2021	DRAGONFLY’S GREEN SHOOTS OF GROWTH DOWN UNDER	Dragonfly Biosciences UK
22-Jul-2021	Increased R&D Investments in Pharmaceutical Industries Advancing The Lab Automation Market	Markets and Markets
22-Jul-2021	£54m construction project in Loughborough creates flexible facility for a growing CRO	Charnwood Campus
22-Jul-2021	Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform	Coave Therapeutics
22-Jul-2021	Sputnik V approved for use in Chile	Russian Direct Investment Fund
22-Jul-2021	Minaris Will Be the Commercial Manufacturer in Europe for Skysona™, bluebird bio’s Gene Therapy for CALD	Minaris Regenerative Medicine GmbH
22-Jul-2021	UK Biobank-PPP expands proteomics study of 53,000 participants to Olink Explore 3072	Olink Holding AB
22-Jul-2021	Appointment of Chief Scientific Officer	Sensyne Health
22-Jul-2021	OncoArendi licenses Cresset molecule design software to advance the development of new therapeutics	Cresset
22-Jul-2021	Calliditas Therapeutics and STADA partner to register and commercialize specialty therapy for IgA Nephropathy in Europe	Calliditas Therapeutics
22-Jul-2021	National Institute for Clinical Excellence (NICE) gives green light for pemigatinib (Pemazyre®), the first targeted therapy for those with the ‘Cinderella’ cancer, cholangiocarcinoma	AMMF
22-Jul-2021	First batch of the Sputnik V vaccine produced in Vietnam	Russian Direct Investment Fund
22-Jul-2021	Almost 70% of Doctors Say Covid-19 Vaccine Rates Would Be Higher If They Could Administer to Their Own Patients, New Survey Shows	Sermo
22-Jul-2021	Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders	Hemab
22-Jul-2021	Novo Holdings co-leads Hemab’s US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders	Novo Holdings